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ABSTRACT
Localized involutional lipoatrophy is a rare, sporadic disease with female tendency and 
characterized by focal loss of adipose tissue. We report two sisters, aged 8 years and 
6 years, who developed asymptomatic depressive areas on the upper left arm and upper 
right arm, respectively. Cutaneous sonography showed slight thickening of the dermis 
and remarkably decreased thickness of the cutaneous fat tissue. Histopathology of a 
biopsy specimen from the elder sister revealed an increase in homogenized collagen 
bundles and entrapment of eccrine glands high in the dermis, as well as small to 
medium-sized lipocytes with a scarcity of inflammatory cells.
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Localized involutional lipoatrophy is a rare presentation with 
a well-defined depression of the skin and noninflammatory 
lobule involution as shown by histology. Some cases occur 
after local injection and the lesions tend to be proximally 
located. Peters and Winkelmann1 first reported this condition 
in 1986 and the involvement of family members has rarely 
been reported since then.2 We present here two Taiwanese 
siblings with localized involutional lipoatrophy.
Case report
An 8-year-old girl presented with a 2-month history of an 
asymptomatic depressive lesion on the lateral side of her 
upper left arm. Physical examination revealed a 3 cm × 4 cm 
well-defined, oval, flesh-colored to faintly ivory-colored 
depression on her upper left arm (Figure 1A). The overlying 
surface was atrophic with telangiectases. Interestingly, her 
6-year-old sister had also had an asymptomatic depressive 
area on her upper right arm for almost 2 months. Clinical 
presentation revealed a 3 cm × 4 cm well-defined, flesh-
colored, oval, depressed area on her upper right arm 
(Figure 1B). There were no inflammatory signs in either le-
sion. Their mother denied any history of trauma or injection 
in the past 1–2 years. Both children were otherwise healthy 
and had no associated medical conditions or drug intake. 
The family of the two patients did not have any symptoms 
related to localized lipoatrophy. Cutaneous sonography in 
both sisters showed a slightly increased thickness of the 
dermis and remarkably decreased thickness of the subcuta-
neous fat tissue compared with the skin on the contralateral 
normal upper arm (Figures 2A and 2B). At the site of the 
lesion in the elder sister, the thickness of the epidermis and 
dermis was 1.6 mm and the subcutaneous fat was 2.2 mm. 
In the healthy skin, the thickness of the epidermis and der-
mis was 1.3 mm and the subcutaneous fat was 3.6 mm.
Laboratory studies including hematologic tests, erythro-
cyte sedimentation rate, and autoantibody screening tests for 
immune disease were within normal limits. We performed 
a skin biopsy on the elder sister, but her mother refused a 
biopsy for the younger sister.
Histopathological examination showed mild epidermal 
atrophy, pandermal fibrosis with loss of the perieccrine fat 
pad, and entrapment of eccrine glands high in the dermis 
(Figure 3A). There were diminutive fat lobules with small 
and atrophic fat cells and a highly prominent vasculature, 
*Corresponding author. Department of Dermatology, Tzu-Chi General Hospital, 707, 
Section 3, Chung Yang Road, Hualien, Taiwan.
E-mail: md.hong@msa.hinet.net
Received: May 21, 2009 • Revised: Jul 15, 2009 • Accepted: Aug 19,2009
114 C.H. Chang et al
simulating embryonic fat (Figure 3B). There was no significant 
dermal or subcutaneous inflammation. Immunoreactivity 
was performed with CD3 (DAKO, Copenhagen, Denmark; 
dilution titer, 1:100), CD20 (DAKO; dilution titer, 1:100), 
CD31 (R&D Systems, Minneapolis, MN; dilution titer, 1:100) 
and CD68 (R&D Systems; dilution titer, 1:100). Scattered 
CD68+ positive macrophages were infiltrated in close 
proximity to atrophic lipo cytes, and there was negative 
staining for T-cells and B-cells with CD3 and CD20 markers 
(Figure 3C). CD31+ endothelial cells in the capillaries also 
showed a prominent vasculature and angioplasia (Figure 3D). 
Direct immunofluorescence study results were negative. 
The diagnosis was localized involutional lipoatrophy. No 
resolution of the skin depressions occurred within 3 months.
Discussion
Localized involutional lipoatrophy involves the loss of adipose 
tissue without preceding clinical or histologic inflammation; 
however, the exact etiopathogenesis is still unclear. The char-
acteristic subcutaneous histopathologic changes simulate 
embryonic adipose tissue. In 1986, Peters and Winkelmann1 
first described this entity and more than 30 cases have since 
been reported. Clinically, localized involutional lipoatrophy 
is an asymptomatic, localized, non-inflammatory and well-
defined depression, mainly on the proximal limbs and but-
tocks. The clinical differential diagnosis includes morphea, 
lichen sclerosis, and atrophoderma of Pasini and Pierini. 
A characteristic feature of localized morphea is that it is well 
circumscribed and ivory or white. As the lesion subsides, 
atrophy becomes evident. It is most frequently encountered 
at a young age. The differential diagnosis must also distin-
guish it from localized involutional lipoatrophy.
Most reported patients were young females (M:F = 2:37) 
and the average age is 31 years (range, 8–67 years; Table 
11–10). However, the remarkable female predominance in 
previous reports is difficult to explain. Most cases were not 
associated with any medical condition. However, some were 
associated with atopic dermatitis, rheumatoid arthritis, and 
vitiligo, except for one family with two involved siblings 
most reported cases have been sporadic.2 Our patients were 
two sisters with no associated medical conditions. Among 
reported patients, 48.7% had a history of a localized in-
jection at the affected site before the development of the 
lipoatrophy. Although local injection may play a role in the 
onset of these lesions, more than half of the patients cannot 
recall any previous injection, as found in our patients. The 
duration of lesion(s) prior to presentation varies from 2 weeks 
to 1 year. This finding could be because the lesions have no 
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Figure 1 (A) Well-demarcated, noninflamed depression on the elder sister’s upper left arm. (B) A depressed, flesh-colored area on the younger 











Figure 2 (A) Slightly increased thickness of the dermis and remarka-
bly decreased thickness of the cutaneous fat tissue on cutaneous 
sonography in the elder sister (arrow). (B) Sonographic appearance of 
the healthy skin on the upper right arm in the elder sister.
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symptoms and patients do not pay attention to any early 
changes in the skin lesion.
Histologically, involuted fat lobules composed of small to 
atrophic lipocytes are embedded in the prominent vasculature 
and hyalinized background, simulating fetal adipose tissue. 
Increased homogenized collagen bundles in the dermis re-
placing subcutaneous fat tissue have been reported.3,4 Some 
patients have epidermal changes with hypopigmentation and 
Table 1 Clinical and histopathologic data from previous cases with localized involutional lipoatrophy.1–10
Reference
 No. of Age 
Sex
 Case(s) of 
Duration Histopathology
 Family
 cases (yr)  prior injection   history
Peters and 6 5–41 5F/1M 1 2 mo–1 yr Small to medium-sized lipocytes with scarcity No
 Winkelmann1       of inflammatory cells
Lo et al2 2 8 1F/1M 2 2–7 mo Atrophic fat cells with prominent vasculature Yes
Sasaki et al3 2 30–32 2F 0 2 wk–4 mo Mucin-phagocytosing histiocytes surrounding No
       shrunken lipocytes
Abbas et al4 2 30–43 2F 0 4–6 mo Diminutive fat lobules, epidermal atrophy No
       and prominent pandermal fibrosis
Ahmed5 1 53 1F 1 6 mo Active macrophages engulfing segments of stromal tissue No
Zalla et al6 1 47 1F 1 1–5 mo Small to medium-sized lipocytes with focally No
       prominent blood vessels
Dahl et al7 16 13–65 16F 9 N/A Fat septa fibrosis and acid mucopolysaccharide No
       within fat lobules
Yamamoto et al8 6 22–50 6F 4 1–2 mo Small to medium-sized lipocytes with a number of capillaries No
Hisamichi et al9 2 23–30 2F 1 1 mo Numerous small adipocytes in hyaline connective tissue No
Cendras et al10 1 67 1F 0 6 wk Reduced size of adipocytes with vascular dilatation No
M = male; F = female; N/A = not available.
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Figure 3 (A) A low power view shows increased collagen bundles and entrapment of the eccrine glands high in the dermis of the elder sister 
(H&E, original magnification 40×). (B) A high power view shows fat lobules composed of small to medium-sized lipocytes with scarcity of inflam-
matory cells involuted to simulate fetal adipose tissue (H&E, 200×). (C) Expression of CD68 positive macrophages in the adipose tissue (CD68, 
200×). (D) Prominent vasculature in the adipose tissue shown by staining with CD31 marker (CD31, 200×).
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In summary, the reason for the development of this con-
dition in both sisters at the same time remains unknown. 
Although their mother does not recall any injection on the 
lesional site, this may be because of recollection bias. 
However, half of the reported cases of localized involu-
tional lipoatrophy were not associated with previous injec-
tions. This may indicate that the lipoatrophy in our patients 
is idiopathic and has an inherited tendency. Further investi-
gation is needed to elucidate the mechanism. A tendency 
of the skin lesions to resolve without treatment has been 
reported, but currently, no local regression or spreading has 
been noted in our patients.
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atrophy.3–5 A scarcity of inflammatory cells with CD68+ and 
mucin-positive macrophages infiltrating involuted lipocytes 
have also been identified in several reports.5–9 Similar to 
previous reports, we found that there were definite dermal 
and subcutaneous pathological findings in the elder sister 
in addition to mild epidermal atrophy. Immunohistochem-
ical stains of the pauci-inflammatory cell revealed positive 
results for macrophages and negative results for T-cells and 
B-cells. It is also important to rule out morphea with sec-
ondary fat changes by histological findings of septal thick-
ening and lymphoplasmacytic inflammation.
The pathogenesis of localized involutional lipoatrophy 
is still unknown. Local injections of insulin, antibiotics, or 
steroids inducing immunologic dysregulation are proposed 
for the development of localized involutional lipoatrophy. 
Lysosomally active macrophages composed of clear vacuoles 
and lipid droplets have been found in close proximity to fat 
cells under electron microscopy.5,7 The activated macro-
phages are supposed to trigger immunologic disorders by 
secreting a variety of cytokines such as fibroblast growth 
factor-2, platelet derived growth factor, interleukin-1, tumor 
necrosis factor-α, and transforming growth factor-ß, resulting 
in involution of the subcutaneous fat tissue.5 We speculate 
that the dermal changes in our patient may have been me-
diated by a localized immune response, which can induce 
cell toxicity and subsequent fibrosis and sclerosis. Among 
all the cytokines in the pathogenesis of localized involu-
tional lipoatrophy, transforming growth factor-ß is thought to 
be involved in the development of morphea, and may thus 
represent a potentially important mediator of the dermal 
changes in our case.
Ultrasonography has been used for objective and non-
invasive monitoring of tumors and chronic skin disease. The 
subcutaneous fat is a markedly hypoechoic area in com-
parison to the dermis. Both morphea and scleroderma are 
characterized by an increment in dermal collagen and the 
images are characterized by augmentation of echoes, with 
an echo-rich band zone at the dermis-subcutis border.11,12 
We used cutaneous sonography in our patients; a slightly in-
creased thickness of the dermis and remarkably decreased 
thickness of the cutaneous fat tissue were noted. This find-
ing may rule out the possibility of other diseases associated 
with localized depression.
